Anest. intenziv. Med. 2010;21(2):78-84

Influence of age on the pharmacodynamic parameters of cisatracurium, rocuronium and vecuronium in males during total intravenous anaesthesia - a prospective studyAnaesthesiology - Original Paper

Adamus Milan
Klinika anesteziologie a resuscitace, Fakultní nemocnice a Lékařská fakulta Univerzity Palackého v Olomouci

Objective:
To compare the pharmacodynamics of cisatracurium, rocuronium and vecuronium following a single dose in young and elderly males during TIVA.

Design:
Clinical, prospective, controlled, randomized study.


Setting:
Department of Anaesthesiology, University Hospital.

Materials and methods:
Following ethics committee approval and patients' informed consent, 240 males of two age groups (20-40, 60-75 years) received cisatracurium, rocuronium or vecuronium (2×ED95). For each patient, neuromuscular monitoring (TOF, electromyography) determined the onset time (maximal T1 depression), clinical duration (25% recovery of T1) and full recovery (TOF-ratio ≥ 0.9). Mann-Whitney or Kruskal-Wallis test were used to compare the differences between young and elderly patients.

Results:
The median onset times (seconds) were 205 vs. 255* for cisatracurium, 95 vs. 133* for rocuronium and 210 vs. 250* for vecuronium in the young and elderly patients, respectively (*p < 0.001). The median clinical duration (minutes) was 44 vs. 43.5 (p = 0.568) for cisatracurium, 36 vs. 58* for rocuronium and 32 vs. 60* for vecuronium in the young and elderly patients, respectively. Finally, the median full recovery times (minutes) were 71 vs. 77 (p = 0.095) for cisatracurium, 60 vs. 103* for rocuronium and 56 vs. 92* for vecuronium, in the young and elderly patients, respectively.

Conclusion:
The onset was slower in the elderly. Both clinical duration and full recovery for rocuronium and vecuronium were longer in the elderly whereas these parameters for cisatracurium were age-independent.

Keywords: pharmacodynamics; cisatracurium; rocuronium; vecuronium; age

Published: April 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Adamus M. Influence of age on the pharmacodynamic parameters of cisatracurium, rocuronium and vecuronium in males during total intravenous anaesthesia - a prospective study. Anest. intenziv. Med. 2010;21(2):78-84.
Download citation

References

  1. Servin, F., Cazalaa, J. B., Levron, J. C. Propofol, Sufentanil, Remifentanil in TCI. Bibliographical study of anesthetic agents used in the Base Primea®, Fresenius Vial. Le Grand Chemin, Brezins (France): Fresenius Vial, 2003.
  2. Fuchs-Buder, T., Claudius, C., Skovgaard, L. T., Eriksson, L. I., Mirakhur, R. K., Viby-Mogensen, J. Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision. Acta Anaesthesiologica Scandinavica, 2007, 51, p. 789-808. Go to original source... Go to PubMed...
  3. Adamus, M., Belohlavek, R. Fuzzy control of neuromuscular block during general anesthesia - system design, development and implementation. International Journal of General Systems, 2007, 36, p. 733-743. Go to original source...
  4. Mencke, T., Soltesz, S., Grundmann, U. et al. Time course of neuromuscular blockade after rocuronium. A comparison between women and men. Anaesthesist, 2000, 49, p. 609-612. Go to original source... Go to PubMed...
  5. Adamus, M., Gabrhelik, T., Marek, O. Influence of gender on the course of neuromuscular block following a single bolus dose of cisatracurium or rocuronium. European Journal of Anaesthesiology, 2008, 25, p. 589-595. Go to original source... Go to PubMed...
  6. Murphy, G. S. Residual Neuromuscular Blockade: Is It A Problem In The Geriatric Patient? Sborník abstrakt, Kongres Perioperative Care For The Geriatric Patient. Praha, 14.-16. červen 2009. CD-ROM.
  7. Sieber, F. E., Pauldine, R. Anesthesia for the Elderly. In Miller, R. D. (editor). Miller's Anesthesia. Philadelphia: Churchill-Livingstone, 2005, p. 2435-2449.
  8. Lien, C. Nondepolarizing Neuromuscular Blocking Agents in the Elderly: Dosing Paradigms Revisited. Sborník abstrakt, Kongres Perioperative Care For The Geriatric Patient. Praha, 14.-16. červen 2009. CD-ROM.
  9. Han, D. W., Chun, D. H., Kweon, T. D., Shin, Y. S. Significance of the injection timing of ephedrine to reduce the onset time of rocuronium. Anaesthesia, 2008, 63, p. 856-860. Go to original source... Go to PubMed...
  10. Szmuk, P., Ezri, T., Chelly, J. E., Katz, J. The onset time of rocuronium is slowed by esmolol and accelerated by ephedrine. Anesthesia and Analgesia, 2000, 90, p. 1217-1219. Go to original source... Go to PubMed...
  11. Hans, P., Welter, P., Dewandre, P. Y., Brichant, J. F., Bonhomme, V. Recovery from neuromuscular block after an intubation dose of cisatracurium and rocuronium in lumbar disc surgery. Acta Anaesthesiologica Belgica, 2004, 55, p. 129-133. Go to original source... Go to PubMed...
  12. Schmith, V. D., Fiedler-Kelly, J., Phillips, L., Grasela, T. H. Jr. Prospective use of population pharmacokinetics/pharmacodynamics in the development of cisatracurium. Pharmaceutical Research, 1997, 14, p. 91-97. Go to original source... Go to PubMed...
  13. Anaesthesiology and Intensive Care in the Czech Republic 2007 [online]. [Cit. 26. 10. 2009]. Dostupný na WWW
  14. http://www.csarim.cz/RSystem/Soubory/anaesthesiology_and_intensive_care_in_the_czech_republic_2007.pdf




Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.